About NeuWave
NeuWave is a company based in Madison (United States) founded in 2004 was acquired by Quantum Surgical in February 2026. NeuWave has raised $52.68 million across 9 funding rounds from investors including HHS, Quantum Surgical and HIG BioHealth Partners. NeuWave operates in a competitive market with competitors including KLOwen, Aibo Medical, The InterMed Group, Panorama Eyecare and Therma Bright, among others.
- Headquarter Madison, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ethicon Us, Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$52.68 M (USD)
in 9 rounds
-
Latest Funding Round
$25 M (USD), Series C
May 28, 2015
-
Investors
HHS
& 7 more
-
Employee Count
Not available
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of NeuWave
NeuWave has successfully raised a total of $52.68M across 9 strategic funding rounds. The most recent funding activity was a Series C round of $25 million completed in May 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in NeuWave
NeuWave has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Quantum Surgical and HIG BioHealth Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999.
|
Locked | Locked | Locked | |
|
Multiple sectors focused seed & early stage VC firm investing in the US, Europe & Asia
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for NeuWave
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NeuWave
Investment portfolio details for NeuWave
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NeuWave
Detailed financials for NeuWave
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neuwave Comparisons
Peer comparison for NeuWave
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NeuWave
NeuWave operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KLOwen, Aibo Medical, The InterMed Group, Panorama Eyecare and Therma Bright, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital tools for orthodontists are provided by KLOwen.
|
|
| Locked | Locked | Locked |
Vascular interventional surgery robot systems are developed by the company.
|
|
| Locked | Locked | Locked |
Healthcare technology management services and equipment are provided.
|
|
| Locked | Locked | Locked |
Physician-led management services for eye care professionals are provided.
|
|
| Locked | Locked | Locked |
Provider of medical device management services
|
Detailed competitors of NeuWave
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neuwave
Complete news archive for NeuWave
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NeuWave
NeuWave was founded in 2004 and raised its 1st funding round 4 years after it was founded.
NeuWave is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.
NeuWave is a funded company, having raised a total of $52.68M across 9 funding rounds to date.
NeuWave Medical has developed the Certus 140 Microwave Ablation System for soft tissue and cancerous tissue ablation including lung, liver, kidney cancers. Also provides probes and surgical tools to support the ablation procedure. Its a hand held device with flexible power delivery settings. They have received 510(k) clearance for their Certus 140TM 2.45 GHz Ablation System. In March 2016, NeuWave Medical was acquired by Ethicon, a division of Johnson Johnson.
NeuWave's top competitors include KLOwen, Therma Bright and The InterMed Group.
NeuWave has 8 investors. Key investors include HHS, Quantum Surgical, HIG BioHealth Partners, Versant Ventures, and Venture Investors.